Manufacturers/American Regent, Inc.

American Regent, Inc.

20 drugs in NADAC|17 Generic,3 Brand

View Recalls (21)

American Regent, Inc. lists 20 NDCs in the CMS NADAC file (17 generic, 3 brand), at an average NADAC of $8.61 per unit, with a week-over-week move of +0.7% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

20

17G / 3B

Avg Price / Unit

$8.6087

$0.07 – $36.83

Avg 7d Change

+0.66%

Across 12 drugs with changes

7d Activity

5↑7↓8 flat

of 20 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Frequently Asked Questions

How many drugs does American Regent, Inc. make?

American Regent, Inc. lists 20 NDCs in the CMS NADAC file — 17 generic and 3 brand products.

What is the average price of American Regent, Inc. drugs?

The average NADAC across American Regent, Inc.'s portfolio is $8.6087 per unit, ranging from $0.0661 to $36.8279.

What types of drugs does American Regent, Inc. make?

American Regent, Inc. makes drugs across 13 FDA pharmacologic classes. The most common by NDC count are Corticosteroid (6), Parenteral Iron Replacement (3), Phosphate Binder (3), Antidote (3), Antidote for Acetaminophen Overdose (3).

Has American Regent, Inc. had any drug recalls?

21 FDA recalls are matched to American Regent, Inc. in the openFDA feed, most recently on Aug 11, 2026.

How has American Regent, Inc.'s pricing changed recently?

Over the past 7 days, 5 American Regent, Inc. products rose and 7 fell, with a portfolio-wide average change of +0.7%.

Drug Portfolio

20 drugs total, 20 shown

Drug ↕Price 7d Change ↕
ESTRADIOL VALERATE 200 MG/5 ML
ESTRADIOL VALERATE
$36.8279
per ML
+5.04%
ESTRADIOL VALERATE 100 MG/5 ML
ESTRADIOL VALERATE
$22.6452
per ML
+5.14%
OLANZAPINE 10 MG VIAL
Olanzapine
$20.9230
per EA
-2.08%
VENOFER 200 MG/10 ML VIAL
iron sucrose
$12.5305
per ML
—
TESTOSTERONE CYP 200 MG/ML
Testosterone Cypionate
$12.3075
per ML
—
VENOFER 100 MG/5 ML VIAL
iron sucrose
$12.2067
per ML
—
VENOFER 100 MG/5 ML VIAL
iron sucrose
$12.2067
per ML
—
BETAMETHASONE SP-AC 30 MG/5 ML
Betamethasone Sodium Phosphate and Betamethasone Acetate
$9.1383
per ML
-1.34%
BETAMETHASONE SP-AC 30 MG/5 ML
Betamethasone Sodium Phosphate and Betamethasone Acetate
$9.1383
per ML
-1.34%
BETAMETHASONE SP-AC 30 MG/5 ML
Betamethasone Sodium Phosphate and Betamethasone Acetate
$9.1383
per ML
-1.34%
HYDROXYZINE 25 MG/ML VIAL
Hydroxyzine Hydrochloride
$2.8346
per ML
—
ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)
acetylcysteine
$2.5539
per ML
-2.48%
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)
acetylcysteine
$2.2455
per ML
+3.80%
CYANOCOBALAMIN 10,000 MCG/10 ML
cyanocobalamin
$2.1337
per ML
—
GLYCOPYRROLATE 0.2 MG/ML VIAL
Glycopyrrolate
$1.5143
per ML
+2.28%
CYANOCOBALAMIN 1,000 MCG/ML VL
cyanocobalamin
$1.4739
per ML
-1.34%
ACETYLCYSTEINE 20% VIAL
acetylcysteine
$1.1883
per ML
—
CYANOCOBALAMIN 30,000 MCG/30 ML
cyanocobalamin
$0.7871
per ML
-0.85%
WATER FOR INJECTION VIAL
Water
$0.3150
per ML
+2.41%
WATER FOR INJECTION VIAL
Water
$0.0661
per ML
—

FDA Recalls (21)

Recalls matched by company name. Verify current status with FDA.

D-0865-2026 →
Ongoing
Class I

Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Initiated: 8/11/2026
D-0797-2026 →
Ongoing
Class II

ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7604-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7604-25), Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0796-2026 →
Ongoing
Class II

ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7504-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7504-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0795-2026 →
Ongoing
Class II

Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile, packaged in a) 1 mL Single-Dose Vial (NDC 0517-1001-01), and b) 25x1 mL Single-Dose Vial (NDC 0517-1001-25), Rx only, AMERICAN REGENT INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0791-2026 →
Ongoing
Class II

Nitroglycerin injection, USP, 50 mg/10 mL (5 mg/mL), packaged in a) 10 mL vials (NDC 0517-4810-01), b) 25x10mL vials (NDC 0517-4810-25) RX only, AMERICAN REGENT, INC., Shirley, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0802-2026 →
Ongoing
Class II

niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0794-2026 →
Ongoing
Class II

AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL MULTIPLE DOSE VIAL FOR IV INFUSION (NDC 0517-9120-01), and b) 25x20 mL MULTIPLE DOSE VIALS (NDC 0517-9120-25), Rx Only, American Regent, Inc., Shirley, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0798-2026 →
Ongoing
Class II

Selenious Acid Injection, USP 12 mcg/2 mL (6 mcg/2mL), For intravenous use, packaged in a) 2mL Single-Dose Vial (NDC 0517-6502-01), and b)10x2mL Single-Dose Vial (NDC 0517-6502-10), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0792-2026 →
Ongoing
Class II

Cyanocobalamin injection USP, 1,000 mcg/mL, For IM or SC Use Only, packaged in a) 1 mL Multi-Dose Vial (NDC 0517-0031-01), and b) 25x1 mL Multi-Dose Vials (NDC 0517-0031-25) Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0801-2026 →
Ongoing
Class II

Tralement (trace elements injection 4*, USP), packaged in a) 1mL Single Dose vials (NDC 0517-9305-01) and b) 5x1mL Single Dose vials (NDC 0517-9305-25), Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0793-2026 →
Ongoing
Class II

Cyanocobalamin injection USP, 10,000 mcg/10 mL (1,000 mcg/mL), For IM or SC Use Only, packaged in a) 10 mL Multi-Dose Vial (NDC 0517-0032-01) and b) 25x10 mL Multi-Dose Vials (NDC 0517-0032-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0799-2026 →
Ongoing
Class II

Multrys (Trace Elements Injection 4, USP), For intravenous infusion, packaged in a) 1 mL Single-Dose Vial (NDC 0517-9302-01), and b) 25x1 mL Single-Dose Vials (NDC 0517-9302-25) Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0800-2026 →
Ongoing
Class I

Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

Initiated: 7/24/2026
D-0494-2026 →
Ongoing
Class III

Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01

Labeling: Missing Label

Initiated: 4/16/2026
D-0398-2025 →
Ongoing
Class II

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for: Civica, Inc., Lehi, UT 84043,Mfd by: American Regent, Inc., New Albany, OH 43064. NDC Carton: 72572-470-10/ NDC Vial: 72572-470-01.

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

Initiated: 4/18/2025
D-0399-2025 →
Ongoing
Class II

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

Initiated: 4/18/2025
D-0081-2025 →
Ongoing
Class II

Venofer (iron sucrose) Injection, USP 50 mg Elemental Iron per 2.5 mL (20 mg/mL), 2.5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451, NDC: 49230-530-01 (vial), NDC: 49230-530-10 (10 x 2.5mL/vial cartons), NDC: 49230-530-25 (25 x 2.5mL/vial cartons).

Presence of Particulate Matter: Potential for glass delamination from the vials.

Initiated: 11/11/2024
D-0082-2025 →
Ongoing
Class II

Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, American Regent, Inc. Shirley, NY 11967, NDC: 0517-2340-01 (vial), NDC: 0517-2340-10 (10 x 5 mL/vial cartons), NDC: 0517-2340-25 (25 x 5 mL/vial cartons).

Presence of Particulate Matter: Potential for glass delamination from the vials.

Initiated: 11/11/2024
D-0080-2025 →
Ongoing
Class II

Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451, NDC: 49230-534-01 (vial), NDC: 49230-534-25 (25 x 5 mL/vial cartons).

Presence of Particulate Matter: Potential for glass delamination from the vials.

Initiated: 11/11/2024
D-0503-2024 →
Terminated
Class II

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054. NDC 72572-470-10

Lack of Assurance of Sterility.

Initiated: 5/14/2024
D-0507-2024 →
Terminated
Class II

Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01

Subpotent product in addition to having out-of-specification results for impurities.

Initiated: 5/13/2024